Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 25,580 | 22,739 | 22,153 | 21,196 | 19,495 |
| Cost of Goods | 9,340 | 9,046 | 8,697 | 8,259 | 7,526 |
| Gross Profit | 16,240 | 13,693 | 13,456 | 12,937 | 11,969 |
| Operating Expenses | 14,978 | 13,995 | 14,884 | 13,364 | 13,642 |
| Operating Income | 1,602 | -256 | -731 | -168 | -1,147 |
| Other Income | 276 | 241 | 239 | 282 | 188 |
| Pre-tax Income | 1,878 | -15 | -492 | 114 | -959 |
| Net Income Continuous | 1,878 | -15 | -492 | 114 | -959 |
| Net Income | $1,878 | $-15 | $-492 | $114 | $-959 |
| EPS Basic Total Ops | 0.02 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.02 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.02 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.02 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.02 | 0.00 | -0.01 | N/A | N/A |
| EBITDA(a) | $1,804 | $-49 | $-515 | $48 | $-875 |